These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21486173)

  • 1. Investment in innovation: lessons learned from China.
    Wiederhold BK
    Cyberpsychol Behav Soc Netw; 2011 Apr; 14(4):181-2. PubMed ID: 21486173
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing number of companies found ineligible for SBIR funding.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
    [No Abstract]   [Full Text] [Related]  

  • 4. Gambling on change. Five big systems buy into a venture capital fund to try to reap profits from the transformation of healthcare.
    Evans M
    Mod Healthc; 2011 Jan; 41(5):6-7, 1. PubMed ID: 21370624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target small firms for antibiotic innovation.
    Hwang TJ; Carpenter D; Kesselheim AS
    Science; 2014 May; 344(6187):967-9. PubMed ID: 24876477
    [No Abstract]   [Full Text] [Related]  

  • 6. Product development. And the winner is...
    Mooney H
    Health Serv J; 2012 Apr; 122(6303):Suppl 26-7. PubMed ID: 22741365
    [No Abstract]   [Full Text] [Related]  

  • 7. Bidding for business. Bond sales getting more competitive; on-line auctions among the options.
    Pallarito K
    Mod Healthc; 1998 Aug; 28(33):37. PubMed ID: 10183086
    [No Abstract]   [Full Text] [Related]  

  • 8. Technology and financing strategies in the development of life science companies.
    Gertler JP; Hu A; Simon J
    Surgery; 2008 Feb; 143(2):198-205. PubMed ID: 18242336
    [No Abstract]   [Full Text] [Related]  

  • 9. Oh no! Not another acronym?
    Wallner PE
    J Am Coll Radiol; 2004 Sep; 1(9):629. PubMed ID: 17411670
    [No Abstract]   [Full Text] [Related]  

  • 10. Federal stimulus adds momentum to sequencing stampede.
    Fox JL
    Nat Biotechnol; 2009 Dec; 27(12):1061-2. PubMed ID: 20010558
    [No Abstract]   [Full Text] [Related]  

  • 11. Bottom-up innovation. Venture capital change may foster entrepreneurial growth.
    Limbacher PB
    Mod Healthc; 1998 Aug; 28(32):64. PubMed ID: 10183072
    [No Abstract]   [Full Text] [Related]  

  • 12. Capital financing demands new, innovative practices.
    Bruton P; Waterman J
    Healthc Financ Manage; 1985 Apr; 39(4):38-46. PubMed ID: 10270192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Paycheck Protection Program on dermatology practices during the COVID-19 pandemic.
    Benlagha I; Nguyen BM
    J Am Acad Dermatol; 2021 Mar; 84(3):775-777. PubMed ID: 33310110
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategic financial planning: opportunities at an inopportune time?
    Cain DM
    Trustee; 1984 Sep; 37(9):29-31. PubMed ID: 10299688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFOs take new tack.
    Pallarito K
    Mod Healthc; 1995 Mar; 25(10):85-6, 88-90, 92-4. PubMed ID: 10140419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capital punishment. Equity drought hits technology and service firms.
    Pallarito K
    Mod Healthc; 1998 Nov; 28(47):56. PubMed ID: 10187700
    [No Abstract]   [Full Text] [Related]  

  • 17. Basic instincts.
    Nat Nanotechnol; 2008 Feb; 3(2):59. PubMed ID: 18654454
    [No Abstract]   [Full Text] [Related]  

  • 18. Can the SBIR and STTR programs advance research goals?
    Ceulemans S; Kolls JK
    Nat Immunol; 2013 Mar; 14(3):192-5. PubMed ID: 23416667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A money-making 'venture'. Healthcare executives need to spend time on research and development via venture capital.
    Cain D
    Mod Healthc; 1999 Nov; 29(45):72. PubMed ID: 10623268
    [No Abstract]   [Full Text] [Related]  

  • 20. UK technology-boost plan disappoints.
    Bhattacharya A
    Nature; 2012 Sep; 489(7416):347. PubMed ID: 22996525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.